Примери за използване на Safety and efficacy data на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
adolescents below 18 years due to a lack of safety and efficacy data.
Dosage in paediatric patients Doribax is not recommended for use in children below 18 years of age due to a lack of safety and efficacy data.
clinical studies and refer to safety and efficacy data of the innovator product.
adolescents below 18 years of age as no safety and efficacy data have been generated in this patient population.
Dosing recommendations for Augmentin SR are supported by extensive clinical safety and efficacy data.
In addition to comparative pharmacokinetic and pharmacodynamic studies, safety and efficacy data may be required, particularly for more complex biological medicines.
For this generic‘hybrid' application, the benefits are extrapolated from the safety and efficacy data for the reference product, Metacam 20 mg/ml.
Limited safety and efficacy data have been collected on dabrafenib in non-Caucasian patients.
As positive safety and efficacy data are gathered, the number of patients is typically increased.
Further studies will be needed to provide relevant safety and efficacy data in this patient population.
No safety and efficacy data are available on re-treatment with crizotinib of patients who received crizotinib in previous lines of therapy.
Important considerations need to be borne in mind before an indication for a biosimilar can be approved based on extrapolated safety and efficacy data.
As positive safety and efficacy data is gathered,
Safety and efficacy data are available which demonstrate that this vaccine can be administered the same day
Safety and efficacy data are available which demonstrate that this vaccine can be mixed
These recommendations follow a review of available safety and efficacy data on codeine when used for pain relief in children,
This Registry will collect long-term safety and efficacy data in patients treated with Aldurazyme as well as data on the natural progression of the disease in patients not on treatment.
animal health or environmental perspective, to complement the safety and efficacy data available at the time of authorisation with additional information following the placing of the product on the market.
Safety and efficacy data are available which demonstrate that this vaccine can be mixed
Safety and efficacy data are available which demonstrate that this vaccine can be given with Porcilis PRRS at the same time at separate sites from 3 weeks of age.